fig3

EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer

Figure 3. EGF stimulation increased resistance to prexasertib when EGFR is not overexpressed. IC50 values are expressed as mean ± SEM. EGF: epidermal growth factor; EGFR: epidermal growth factor receptor; SEM: standard error of the mean

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/